These findings are consistent with reports implicating C9 in vascular damage in sepsis and atherosclerosis models [59,60,61], and they suggest that C9-enriched adiposomes may represent a previously underappreciated mechanism of complement-mediated vascular dysfunction in obesity. This evidence concerns the gene C9 and obesity disorder.